Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017 (2017), Article ID 1950724, 4 pages
https://doi.org/10.1155/2017/1950724
Case Report

Gelatinous Marrow Transformation Associated with Imatinib: Case Report and Literature Review

1Department of Hematology and Oncology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
2Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA
3Endocrinology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
4Department of Pathology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA

Correspondence should be addressed to E. Chang

Received 1 November 2016; Accepted 14 December 2016; Published 4 January 2017

Academic Editor: Yusuke Shiozawa

Copyright © 2017 E. Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Roger and M. H. Josué, “Des modifications histologiques dellamoelle osseuse dans l'inanition,” Comptes Rendus Société de Biologie, vol. 2, pp. 417–419, 1900. View at Google Scholar
  2. J. Böhm, “Gelatinous transformation of the bone marrow: the spectrum of underlying diseases,” The American Journal of Surgical Pathology, vol. 24, no. 1, pp. 56–65, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Sen, S. Singh, H. Singh, A. Gupta, and J. Sen, “Clinical profile in gelatinous bone marrow transformation,” Journal of Association of Physicians of India, vol. 51, pp. 585–588, 2003. View at Google Scholar · View at Scopus
  4. T. R. Paul, S. G. Uppin, M. S. Uppin, R. T. Jacob, D. R. Rao, and S. J. Rajappa, “Evaluation of cytopenias occurring in imatinib treated Chronic myeloid leukemia (CML) patients,” Indian Journal of Hematology and Blood Transfusion, vol. 26, no. 2, pp. 56–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Ram, A. Gafter-Gvili, E. Okon, I. Pazgal, O. Shpilberg, and P. Raanani, “Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?” Acta Haematologica, vol. 119, no. 2, pp. 104–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. F. S. Hong, C. A. Mitchell, and D. Zantomio, “Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia,” Pathology, vol. 42, no. 1, pp. 84–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Agrawal, P. Sharma, V. Narang, N. Varma, P. Malhotra, and S. Varma, “Gelatinous marrow transformation in an imatinib-treated CML patient with pancytopenia following severe sepsis,” Indian Journal of Hematology and Blood Transfusion, vol. 30, no. 1, pp. 72–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. B. H. Srinivas, T. R. Paul, S. G. Uppin, M. S. Uppin, R. T. Jacob, and D. Raghunadharao, “Morphologic changes in the bone marrow in patients of chronic myeloid leukemia (CML) treated with imatinibmesylate,” Indian Journal of Hematology and Blood Transfusion, vol. 28, no. 3, pp. 162–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Thakral, B. Higa, G. Venkataraman, and M. M. Velankar, “Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML),” Pathology, vol. 44, no. 1, 59 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Seaman, C. R. Kjeldsberg, and A. Linker, “Gelatinous transformation of the bone marrow,” Human Pathology, vol. 9, no. 6, pp. 685–692, 1978. View at Publisher · View at Google Scholar · View at Scopus
  11. R. S. Taichman, “Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche,” Blood, vol. 105, pp. 2631–2639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. W. P. Cawthorn, E. L. Scheller, B. S. Learman et al., “Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction,” Cell Metabolism, vol. 20, no. 2, pp. 368–375, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Fierro, T. Illmer, D. Jing et al., “Inhibition of platelet-derived growth factor receptorβ by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro,” Cell Proliferation, vol. 40, no. 3, pp. 355–366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Devlin, A. M. Cloutier, N. A. Thomas et al., “Caloric restriction leads to high marrow adiposity and low bone mass in growing mice,” Journal of Bone and Mineral Research, vol. 25, no. 9, pp. 2078–2088, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Abella, E. Feliu, I. Granada et al., “Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings,” American Journal of Clinical Pathology, vol. 118, no. 4, pp. 582–588, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Zoncu, A. Efeyan, and D. M. Sabatini, “MTOR: from growth signal integration to cancer, diabetes and ageing,” Nature Reviews Molecular Cell Biology, vol. 12, no. 1, pp. 21–35, 2011. View at Publisher · View at Google Scholar · View at Scopus